2025 SIS指南:儿童腹腔感染的预防和管理(更新版)

发布日期:
2025-10-13
英文标题:
Surgical Infection Society Guidelines on the Prevention and Management of Pediatric Intra-Abdominal Infection: 2025 Update
出处:
Surg Infect (Larchmt) . 2025 Oct 13.
AI大纲:

Introduction

  • Focus on pediatric patients (age ≤18)
  • “IAI” usually refers to complicated IAI
  • Exclusions: certain disease processes, diagnostic methods
  • Emphasis on risk - stratification for treatment

Infection Control and Prevention

  • 建议实施前瞻性护理感染控制和预防策略(1 - B级)
  • 基于单中心RCT研究
    • 研究对象:100例择期开腹手术儿科患者
    • 排除标准:严重心、肝、肾功能不全等情况
    • 干预措施:心理支持、术前准备、感染控制协议等
    • 主要结局:手术切口愈合等级、手术部位感染等
    • 结果:干预组伤口愈合、并发症和感染情况改善,患者满意度高

Antimicrobial Therapy

Beta - Lactamase Inhibitor Combinations

  • Ceftolozane - tazobactam
    • Recommend for empiric therapy (Grade 1 - B)
    • Suggest for higher - risk patients (Grade 2 - C)
  • Ceftazidime - avibactam
    • Recommend for empiric therapy (Grade 1 - B)
    • Suggest for higher - risk patients (Grade 2 - C)

Fluoroquinolones

  • Moxifloxacin
    • Recommend against for empiric therapy (Grade 1 - B)

Carbapenems

  • Ertapenem
    • Recommend for empiric therapy (Grade 1 - A)

Infant Populations

Metronidazole

  • Recommend as anti - anaerobic agent in combination for empiric therapy (Grade 1 - B)

Premature Infants

  • Recommend ampicillin, gentamicin, and metronidazole combination (Grade 1 - B)
  • Recommend ampicillin, gentamicin, and clindamycin combination (Grade 1 - B)
  • Recommend piperacillin - tazobactam and gentamicin combination (Grade 1 - B)

Anti - enterococcal Therapy

  • Suggest against empiric therapy targeting Enterococcus spp. in lower - risk CA - IAI patients (Grade 2 - B)

Acute Appendicitis

Complicated Appendicitis

  • Piperacillin - tazobactam
    • Recommend for post - operative therapy of perforated appendicitis (Grade 1 - B)
  • Ertapenem
    • Recommend for post - operative therapy of perforated appendicitis (Grade 1 - A)
  • IV to Oral Transition
    • Recommend transitioning from IV to oral antibiotics after adequate source control (Grade 1 - A)
  • Shorter Antibiotic Courses
    • Recommend shorter courses (≤7 days) of post - operative antibiotics (Grade 1 - A)

Previous Guideline Recommendations

  • 纳入2017年强推荐(1类)、高至中等质量(A或B级)建议

Specific Recommendations

Source Control

  • 治疗失败的儿科患者参照成人处理(1 - C级)
  • 穿孔阑尾炎术后脓肿患儿不延长IV抗生素疗程(1 - C级)
  • 小于1个月坏死性小肠结肠炎或肠穿孔患儿采取剖腹手术或腹腔引流(1 - A级)

Antimicrobial Therapy

Empiric Therapy

  • 大于1个月低风险患者用头孢噻肟或头孢曲松加甲硝唑或厄他培南(1 - A级)
  • 社区获得性IAI低风险患儿用标准儿科剂量抗菌剂(1 - B级)

Antimicrobial Stewardship

  • 大于1个月患儿充分源控制后抗菌治疗限5天(1 - A级)
  • 源控制充分患者用口服抗菌剂完成5天疗程(1 - B级)
  • 源控制充分患者除非完成5天疗程,否则不额外门诊IV抗菌治疗(1 - B级)

Discussion

  • 指南更新或验证既往建议,引入新建议
  • 提供证据支持临床决策
  • 存在未解决问题
    • 未对单纯性阑尾炎抗菌管理进行研究
    • 非阑尾炎小儿IAI研究不足
    • 预测治疗失败工具缺乏
    • 有效抗生素剂量研究少
    • 新型抗菌剂儿科应用受限
    • 研究结果对其他腹部疾病适用性有限

Special Findings

  • 穿孔阑尾炎腹腔镜切除术后,哌拉西林 - 他唑巴坦治疗效果优于头孢曲松加甲硝唑,但需更多研究验证

Summary

  • 提供最新小儿IAI防治建议
  • 需大规模RCT研究解决未决问题
展开全部

部分内容仅可在
临床指南app 查看下载

阅读免费指南
发送到邮箱

收藏

分享

评论
提交评论
6784435
2025.11.04
回复
回复小肥医:多谢
小肥医
2025.10.16
回复
真是医务工作者的好工具
/ 没有更多了 /
置顶